Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Scientific Reports|June 11, 2026
Circulating IGF2BP3 enables risk stratification and predicts treatment response in Ewing sarcomaCaterina Mancarella, Alessandra De Feo, Irene Dirignani, et al.
Molecular Cancer Therapeutics|October 20, 2021
Targeting CD99 Compromises the Oncogenic Effects of the Chimera EWS-FLI1 by Inducing Reexpression of Zyxin and Inhibition of GLI1 ActivityTommaso Balestra, Maria Cristina Manara, Maria Antonella Laginestra, et al.
International Journal of Cancer|June 23, 2009
Biological indicators of prognosis in Ewing's sarcoma: an emerging role for lectin galactoside-binding soluble 3 binding protein (LGALS3BP)Diana Zambelli, Monia Zuntini, Filippo Nardi, et al.
Molecular Biology of the Cell|January 20, 2006
CD99 acts as an oncosuppressor in osteosarcomaMaria Cristina Manara, Ghislaine Bernard, Pier-Luigi Lollini, et al.
Oncogene|June 9, 2004
Molecular mechanisms of CD99-induced caspase-independent cell death and cell-cell adhesion in Ewing's sarcoma cells: actin and zyxin as key intracellular mediatorsVanessa Cerisano, Yan Aalto, Stefania Perdichizzi, et al.
Frontiers in Endocrinology|June 17, 2022
Novel Targeting of DNA Methyltransferase Activity Inhibits Ewing Sarcoma Cell Proliferation and Enhances Tumor Cell Sensitivity to DNA Damaging Drugs by Activating the DNA Damage ResponseCamilla Cristalli, Maria Cristina Manara, Sergio Valente, et al.
The Journal of Pathology|October 1, 2011
miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancyFumihiko Nakatani, Manuela Ferracin, Maria Cristina Manara, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|March 29, 2014
CD99 drives terminal differentiation of osteosarcoma cells by acting as a spatial regulator of ERK 1/2Marika Sciandra, Maria Teresa Marino, Maria Cristina Manara, et al.
BMC Cancer|March 1, 2014
An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomasClara Guerzoni, Stefano Amatori, Luca Giorgi, et al.
Molecular Cancer Therapeutics|July 1, 2018
A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma TherapyMaria Cristina Manara, Sergio Valente, Camilla Cristalli, et al.
Pageof 8